Amidine derivatives which are inhibitors of nitric oxide synthase
申请人:——
公开号:US20020137750A1
公开(公告)日:2002-09-26
There are provided novel compounds of formula (I)
1
wherein R
1
, R
2
, X, Y and Z are as defined in the Specification and optical isomers, racemates and tautomers thereof and pharmaceutically acceptable salts thereof; tocether with processes for their preparation, compositions containing them and their use in therapy. The compounds are inhibitors of the enzyme nitric oxide synthase.
There are provided novel compounds of formula (I)
1
wherein R
1
, R
2
, R
3
, X and Z are as defined in the Specification and optical isomers, racemates and tautomers thereof and pharmaceutically acceptable salts thereof; together with processes for their preparation, compositions containing them and their use in therapy. The compounds are inhibitors of the enzyme nitric oxide synthase.
Synthesis of derivatives of dihydro-1,2-oxazine and tetrahydro-1,2-diazine from (4-chlorobutanoyl)-alkoxybenzenes
作者:N. N. Yusubov、Shaban Radvan、V. M. Ismailov、N. F. Dzhanibekov
DOI:10.1007/bf00864209
日期:1992.7
The reaction of (4-chlorobutanoyl)alkoxybenzenes with hydroxylamine and 2,4-dinitrophenylhydrazine gave dihydro-1,2-oxazines and tetrahydro-1,2-diazines, respectively.
[EN] AMIDINE DERIVATIVES WHICH ARE INHIBITORS OF NITRIC OXIDE SYNTHASE<br/>[FR] DERIVES D'AMIDINE INHIBITEURS DE L'OXYDE NITRIQUE SYNTHASE
申请人:ASTRAZENECA AB
公开号:WO2001046170A1
公开(公告)日:2001-06-28
There are provided novel compounds of formula (I) wherein R?1, R2, R3¿, X and Z are as defined in the Specification and optical isomers, racemates and tautomers thereof and pharmaceutically acceptable salts thereof; together with processes for their preparation, compositions containing them and their use in therapy. The compounds are inhibitors of the enzyme nitric oxide synthase.
[EN] AMIDINE DERIVATIVES WHICH ARE INHIBITORS OF NITRIC OXIDE SYNTHASE<br/>[FR] DERIVES D'AMIDINE INHIBITEURS D'OXYDE NITRIQUE SYNTHASE
申请人:ASTRAZENECA AB
公开号:WO2001046171A1
公开(公告)日:2001-06-28
There are provided novel compounds of formula (I) wherein R1, R2, X, Y and Z are as defined in the Specification and optical isomers, racemates and tautomers thereof and pharmaceutically acceptable salts thereof; together with processes for their preparation, compositions containing them and their use in therapy. The compounds are inhibitors of the enzyme nitric oxide synthase.